299169-95-2 Usage
General Description
3-(3-Iodophenyl)-Beta-Alanine is a chemical compound with the molecular formula C9H10NO3I. It is a derivative of beta-alanine, an amino acid that is a component of carnosine and anserine. The presence of an iodine atom on the phenyl ring makes this compound useful in the study of iodine-containing compounds and their behavior in biological systems. It has potential applications in medicinal chemistry as a building block for the synthesis of novel compounds with biological activity. 3-(3-Iodophenyl)-Beta-Alanine is also of interest in the field of positron emission tomography (PET), where iodine-containing compounds are used as tracers for imaging of brain and thyroid function.
Check Digit Verification of cas no
The CAS Registry Mumber 299169-95-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,1,6 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 299169-95:
(8*2)+(7*9)+(6*9)+(5*1)+(4*6)+(3*9)+(2*9)+(1*5)=212
212 % 10 = 2
So 299169-95-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10INO2/c10-7-3-1-2-6(4-7)8(11)5-9(12)13/h1-4,8H,5,11H2,(H,12,13)
299169-95-2Relevant articles and documents
HETERODIMERS OF GLUTAMIC ACID
-
Page/Page column 11-12, (2008/12/07)
Compounds of Formula (Ia) wherein R is a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl, a C1-C6 substituted or unsubstituted alkyl or —NR′R′, Q is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)pY is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)p Z is H or C1-C4 alkyl,R′ is H, C(O), S(O)2, C(O)2, a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl or a C1-C6 substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C6-C12 heteroaryl, —NR′R′ or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
